PMC:7441788 / 1144-1775 14 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 146-249 | Sentence | denotes | Adverse effects, including prolonged QT interval after taking CQ/HCQ, may develop in COVID-19 patients. |
| T16 | 250-541 | Sentence | denotes | Therefore, current data are not sufficient enough to support the use of CQ/HCQ as therapies for COVID-19 and increasing caution should be taken about the application of CQ/HCQ in COVID-19 before conclusive findings are obtained by well-designed, multi-center, randomized, controlled studies. |
| T17 | 543-545 | Sentence | denotes | 1. |
| T18 | 547-559 | Sentence | denotes | Introduction |